Asie · Bourse & Finance · Pulse (Maeil Business)

Korea’s first homegrown obesity drug wins approval

Publié par Pulse (Maeil Business) · Corée du Sud il y a 15 h

Hanmi Pharmaceutical’s obesity drug Epe has won regulatory approval and is set to launch by year-end, becoming South Korea’s first domestically developed glucagon-like peptide-1…

Lire l'article complet sur Pulse (Maeil Business) Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (pulse.mk.co.kr)

Korea’s first homegrown obesity drug wins approval

À lire aussi

Oil rises as Middle East supply concerns persist amid shipping attacks

Lenovo launches AI Express with Nvidia

Indian Hotels, NALCO among Ajit Mishra's 3 stock recommendations for today

Jubilant FoodWorks shares in focus after Q2 revenue rises 12%, Domino’s India LFL at 4%

CBI wants more time to probe NEET paper leak

Top stocks to watch today: TCS, Tata Steel, Reliance, Sun Pharma shares in focus on Thursday, 8 October | Full list

Korea’s first homegrown obesity drug wins approval

Partager

À lire aussi

Oil rises as Middle East supply concerns persist amid shipping attacks

Lenovo launches AI Express with Nvidia

Indian Hotels, NALCO among Ajit Mishra's 3 stock recommendations for today

Jubilant FoodWorks shares in focus after Q2 revenue rises 12%, Domino’s India LFL at 4%

CBI wants more time to probe NEET paper leak

Top stocks to watch today: TCS, Tata Steel, Reliance, Sun Pharma shares in focus on Thursday, 8 October | Full list